10x Genomics, Inc. — Director's Dealing 2021

Mar 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-03-08

Reporting Person: McAnear Justin J. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-08	Class A Common Stock	M	10000	$5.04	Acquired	30774	Direct
2021-03-08	Class A Common Stock	S	1022	$141.2499	Disposed	29752	Direct
2021-03-08	Class A Common Stock	S	400	$142.485	Disposed	29352	Direct
2021-03-08	Class A Common Stock	S	1100	$145.0255	Disposed	28252	Direct
2021-03-08	Class A Common Stock	S	1902	$145.8998	Disposed	26350	Direct
2021-03-08	Class A Common Stock	S	1476	$146.8784	Disposed	24874	Direct
2021-03-08	Class A Common Stock	S	200	$148.08	Disposed	24674	Direct
2021-03-08	Class A Common Stock	S	1100	$149.4282	Disposed	23574	Direct
2021-03-08	Class A Common Stock	S	1200	$150.2175	Disposed	22374	Direct
2021-03-08	Class A Common Stock	S	800	$151.2213	Disposed	21574	Direct
2021-03-08	Class A Common Stock	S	400	$152.0825	Disposed	21174	Direct
2021-03-08	Class A Common Stock	S	300	$154.1367	Disposed	20874	Direct
2021-03-08	Class A Common Stock	S	100	$154.82	Disposed	20774	Direct
2021-03-10	Class A Common Stock	M	9583	$11.48	Acquired	30357	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-08	Stock Option (right to buy)	$5.04	M	10000	Disposed	2028-11-02	Class A Common Stock (10000)	Direct
2021-03-10	Stock Option (right to buy)	$11.48	M	9583	Disposed	2029-05-10	Class A Common Stock (9583)	Direct

Footnotes

F1: This option exercise was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F3: This transaction was executed in multiple trades at prices ranging from $140.87 to $141.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $142.07 to $142.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $144.35 to $145.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $145.36 to $146.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $146.36 to $147.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $147.76 to $148.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $148.82 to $149.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: This transaction was executed in multiple trades at prices ranging from $149.82 to $150.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F11: This transaction was executed in multiple trades at prices ranging from $150.85 to $151.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F12: This transaction was executed in multiple trades at prices ranging from $151.96 to $152.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F13: This transaction was executed in multiple trades at prices ranging from $153.58 to $154.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F14: This option, originally for 600,000 shares, of which 149,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F15: This option, originally for 20,000 shares, of which 9,583 shares have been exercised, vested as to one forty-eighth of the shares on May 1, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.